Anti-TNF-alpha therapy augments DPP IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in the circulation of rheumatoid arthritis patients
Publication
, Conference
Cuchacovich, M; Mavropoulos, J; Carolina, L; Carlos, AJ; Gatica, H; Pizzo, S; Sabugo, F; Gonzalez-Gronow, M
Published in: ANNALS OF THE RHEUMATIC DISEASES
July 1, 2005
Duke Scholars
Published In
ANNALS OF THE RHEUMATIC DISEASES
EISSN
1468-2060
ISSN
0003-4967
Publication Date
July 1, 2005
Volume
64
Start / End Page
173 / 173
Location
Vienna, AUSTRIA
Publisher
BMJ PUBLISHING GROUP
Conference Name
Annual European Congress of Rheumatology
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cuchacovich, M., Mavropoulos, J., Carolina, L., Carlos, A. J., Gatica, H., Pizzo, S., … Gonzalez-Gronow, M. (2005). Anti-TNF-alpha therapy augments DPP IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in the circulation of rheumatoid arthritis patients. In ANNALS OF THE RHEUMATIC DISEASES (Vol. 64, pp. 173–173). Vienna, AUSTRIA: BMJ PUBLISHING GROUP.
Cuchacovich, M., J. Mavropoulos, L. Carolina, A. J. Carlos, H. Gatica, S. Pizzo, F. Sabugo, and M. Gonzalez-Gronow. “Anti-TNF-alpha therapy augments DPP IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in the circulation of rheumatoid arthritis patients.” In ANNALS OF THE RHEUMATIC DISEASES, 64:173–173. BMJ PUBLISHING GROUP, 2005.
Cuchacovich M, Mavropoulos J, Carolina L, Carlos AJ, Gatica H, Pizzo S, et al. Anti-TNF-alpha therapy augments DPP IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in the circulation of rheumatoid arthritis patients. In: ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP; 2005. p. 173–173.
Cuchacovich, M., et al. “Anti-TNF-alpha therapy augments DPP IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in the circulation of rheumatoid arthritis patients.” ANNALS OF THE RHEUMATIC DISEASES, vol. 64, BMJ PUBLISHING GROUP, 2005, pp. 173–173.
Cuchacovich M, Mavropoulos J, Carolina L, Carlos AJ, Gatica H, Pizzo S, Sabugo F, Gonzalez-Gronow M. Anti-TNF-alpha therapy augments DPP IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in the circulation of rheumatoid arthritis patients. ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP; 2005. p. 173–173.
Published In
ANNALS OF THE RHEUMATIC DISEASES
EISSN
1468-2060
ISSN
0003-4967
Publication Date
July 1, 2005
Volume
64
Start / End Page
173 / 173
Location
Vienna, AUSTRIA
Publisher
BMJ PUBLISHING GROUP
Conference Name
Annual European Congress of Rheumatology
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences